JNJ-67896062/ACT-064922 ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
86 | 肺動脈性肺高血圧症 | 1 |
86. 肺動脈性肺高血圧症
臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2022-002754-74-PL (EUCTR) | 15/11/2022 | Macitentan pharmacokinetics (PK) in children below 2 years of age | A multicenter, open-label, single-arm study to assess the pharmacokinetics and safety of macitentan in children aged 1 month to <2 years with pulmonary arterial hypertension | Pulmonary Arterial Hypertension MedDRA version: 21.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] | Product Name: Macitentan Product Code: JNJ-67896062/ACT-064922 INN or Proposed INN: Macitentan Other descriptive name: ACT-064992 Product Name: Macitentan Product Code: JNJ-67896062/ACT-064922 INN or Proposed INN: Macitentan Other descriptive name: ACT-064992 | ACTELION Pharmacteuticals Ltd. | NULL | NA | Female: yes Male: yes | 10 | Phase 1 | Turkey;Belgium;United States;Poland;Italy;Germany;Spain |